Penumbra Pulls Aneurysm Device Over Deadly Defects
The U.S. Food and Drug Administration said Wednesday that Penumbra Inc. had recalled more than 260 lots of a device used to treat brain aneurysms over concerns that a defect could...To view the full article, register now.
Already a subscriber? Click here to view full article